Logo image of IVX.CA

INVENTRONICS LTD (IVX.CA) Stock Fundamental Analysis

TSX-V:IVX - TSX Venture Exchange - CA4612082095 - Common Stock - Currency: CAD

0.72  -0.01 (-1.37%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IVX. IVX was compared to 4 industry peers in the Building Products industry. Both the profitability and the financial health of IVX get a neutral evaluation. Nothing too spectacular is happening here. IVX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year IVX was profitable.
IVX had a positive operating cash flow in the past year.
Of the past 5 years IVX 4 years were profitable.
In the past 5 years IVX always reported a positive cash flow from operatings.
IVX.CA Yearly Net Income VS EBIT VS OCF VS FCFIVX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

IVX's Return On Assets of 1.84% is on the low side compared to the rest of the industry. IVX is outperformed by 75.00% of its industry peers.
The Return On Equity of IVX (4.61%) is worse than 75.00% of its industry peers.
IVX has a Return On Invested Capital of 3.94%. This is in the lower half of the industry: IVX underperforms 75.00% of its industry peers.
IVX had an Average Return On Invested Capital over the past 3 years of 16.93%. This is significantly above the industry average of 4.90%.
The last Return On Invested Capital (3.94%) for IVX is well below the 3 year average (16.93%), which needs to be investigated, but indicates that IVX had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.84%
ROE 4.61%
ROIC 3.94%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
IVX.CA Yearly ROA, ROE, ROICIVX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

The Profit Margin of IVX (1.55%) is worse than 75.00% of its industry peers.
The Operating Margin of IVX (3.92%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of IVX has declined.
IVX has a worse Gross Margin (17.94%) than 75.00% of its industry peers.
IVX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.92%
PM (TTM) 1.55%
GM 17.94%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
IVX.CA Yearly Profit, Operating, Gross MarginsIVX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IVX is creating value.
Compared to 1 year ago, IVX has about the same amount of shares outstanding.
Compared to 5 years ago, IVX has more shares outstanding
The debt/assets ratio for IVX has been reduced compared to a year ago.
IVX.CA Yearly Shares OutstandingIVX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IVX.CA Yearly Total Debt VS Total AssetsIVX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

IVX has an Altman-Z score of 2.41. This is not the best score and indicates that IVX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.41, IVX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of IVX is 4.28, which is a neutral value as it means it would take IVX, 4.28 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.28, IVX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
IVX has a Debt/Equity ratio of 0.90. This is a neutral value indicating IVX is somewhat dependend on debt financing.
IVX has a Debt to Equity ratio of 0.90. This is in the lower half of the industry: IVX underperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 4.28
Altman-Z 2.41
ROIC/WACC0.47
WACC8.39%
IVX.CA Yearly LT Debt VS Equity VS FCFIVX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

IVX has a Current Ratio of 2.34. This indicates that IVX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IVX (2.34) is better than 100.00% of its industry peers.
IVX has a Quick Ratio of 1.54. This is a normal value and indicates that IVX is financially healthy and should not expect problems in meeting its short term obligations.
IVX has a Quick ratio of 1.54. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.54
IVX.CA Yearly Current Assets VS Current LiabilitesIVX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

2

3. Growth

3.1 Past

IVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 113.76%, which is quite impressive.
Looking at the last year, IVX shows a small growth in Revenue. The Revenue has grown by 4.99% in the last year.
The Revenue has been growing slightly by 2.21% on average over the past years.
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVX.CA Yearly Revenue VS EstimatesIVX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 36.00, the valuation of IVX can be described as expensive.
Based on the Price/Earnings ratio, IVX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.48, IVX is valued a bit more expensive.
Industry RankSector Rank
PE 36
Fwd PE N/A
IVX.CA Price Earnings VS Forward Price EarningsIVX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IVX is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IVX is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.27
EV/EBITDA 11.2
IVX.CA Per share dataIVX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INVENTRONICS LTD

TSX-V:IVX (8/8/2025, 7:00:00 PM)

0.72

-0.01 (-1.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.51M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP430.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 36
Fwd PE N/A
P/S 0.48
P/FCF 6.27
P/OCF 4.79
P/B 1.43
P/tB 1.43
EV/EBITDA 11.2
EPS(TTM)0.02
EY2.78%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY15.94%
OCF(TTM)0.15
OCFY20.88%
SpS1.5
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.84%
ROE 4.61%
ROCE 5.84%
ROIC 3.94%
ROICexc 4.34%
ROICexgc 4.34%
OM 3.92%
PM (TTM) 1.55%
GM 17.94%
FCFM 7.65%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
ROICexc(3y)18.71%
ROICexc(5y)18%
ROICexgc(3y)18.71%
ROICexgc(5y)18%
ROCE(3y)25.1%
ROCE(5y)24.63%
ROICexcg growth 3Y-68.88%
ROICexcg growth 5Y-39.12%
ROICexc growth 3Y-68.88%
ROICexc growth 5Y-39.12%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
F-Score7
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 4.28
Debt/EBITDA 4.53
Cap/Depr 86.5%
Cap/Sales 2.37%
Interest Coverage 1.99
Cash Conversion 150.62%
Profit Quality 494.69%
Current Ratio 2.34
Quick Ratio 1.54
Altman-Z 2.41
F-Score7
WACC8.39%
ROIC/WACC0.47
Cap/Depr(3y)281.39%
Cap/Depr(5y)239.45%
Cap/Sales(3y)5.39%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.55%
EBIT growth 3Y-69.33%
EBIT growth 5Y-34.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.84%
FCF growth 3Y-16.33%
FCF growth 5Y11.05%
OCF growth 1Y-74.33%
OCF growth 3Y-11.65%
OCF growth 5Y14.04%